AMETEK shares surge on Q2 beat and raised guidance
Berwyn-based AMETEK reported second-quarter earnings that exceeded Wall Street forecasts, prompting management to upgrade full-year outlook and analysts to maintain bullish sentiment.
Shares of AMETEK Inc have significantly outperformed the broader market, climbing 38.6 per cent over the past 12 months compared to a 20.2 per cent rise in the S&P 500. Year-to-date in 2026, the stock has gained 26.2 per cent, further extending its lead over the index’s 13.2 per cent appreciation. This momentum follows strong second-quarter results that surpassed consensus expectations for both earnings and revenue, underpinned by robust demand across semiconductor, aerospace, and medical technology sectors.
The company reported second-quarter adjusted earnings per share of $2.09, beating the consensus estimate of $1.99, while revenue reached $2.04 billion against forecasts of $1.96 billion. Chief Executive David Zapico highlighted double-digit organic sales growth and a 25 per cent increase in record orders, bringing the backlog to $4.1 billion. Approximately 80 per cent of this backlog is expected to ship within the next 12 months, providing visibility into near-term performance.
Management has raised its full-year guidance, citing artificial intelligence, defence, and power grid modernisation as durable growth drivers. The Electronic Instruments division benefited from demand for AI-driven semiconductor equipment and power solutions, while the Electromechanical segment saw strength in medical technology and automation. The company has now beaten consensus estimates in each of the last four quarters, reinforcing its track record of financial discipline.
Analyst sentiment remains positive, with a consensus rating of Moderate Buy among 21 coverage peers. The breakdown includes 13 Strong Buy ratings, one Moderate Buy, and seven Holds. TD Cowen recently maintained a Buy rating and raised its price target to $275, aligning with the mean target. The highest street target stands at $316, implying a 22.2 per cent premium to current levels, while the mean target suggests a 6.4 per cent upside.
Looking ahead, analysts expect full-year adjusted earnings per share to fall between $8.20 and $8.30. For the fiscal year ending in December, diluted earnings per share are projected to grow 12.1 per cent to $8.33. Mergers and acquisitions are also expected to contribute to growth, with the pending acquisition of Indicor and the integration of FARO anticipated to enhance margins and top-line expansion.
